Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Poland.
Students' Research Group "Alveolus", Medical University of Warsaw, Poland.
Cardiol J. 2020;27(3):254-261. doi: 10.5603/CJ.a2018.0137. Epub 2018 Nov 8.
Epidemiological data on the causes of pleural effusion (PE) are scarce. Data on the local prevalence of various causes of PE may play a crucial role in the management strategy of patients with PE. The aim of the study was to investigate the causes of PE and to assess 30-day mortality rate in unselected adult patients treated in a large, multidisciplinary hospital.
Retrospective analysis of medical records, including chest radiographs, of 2835 consecutive patients admitted to the hospital was performed. Radiograhic signs of PE were found in 195 of 1936 patients in whom chest radigraphs were available. These patients formed the study group.
The leading causes of PE were as follows: congestive heart failure (CHF; 37.4%), pneumonia (19.5%), malignancy (15.4%), liver cirrhosis (4.2%) and pulmonary embolism. The cause of PE in 6.7% patients was not established. There was a significant predominance of small volume PE as compared to a moderate or large volume PEs (153, 28 and 14 patients, respectively). Almost 80% of patients with CHF presented with small volume PE, while almost 50% of patients with malignant PE demonstrated moderate or large volume PE. Thirty-day mortality rate ranged from 0% for tuberculous pleurisy to 40% for malignant PE (MPE).
Pleural effusion was found in 10.1% of patients treated in a large multidisciplinary hospital. CHF was the leading cause of PE. Although 30-day mortality in patients with CHF was rela-tively high, it was lower than that in parapneumonic PE and MPE.
关于胸腔积液(PE)病因的流行病学数据很少。有关胸腔积液各种病因的本地患病率的数据可能在胸腔积液患者的管理策略中起关键作用。本研究的目的是调查胸腔积液的病因,并评估在一家大型多学科医院治疗的未选择的成年患者的 30 天死亡率。
对 1936 名有胸片的患者中的 195 名进行了回顾性分析,这些患者的医疗记录包括胸部 X 光片。这些患者构成了研究组。
胸腔积液的主要病因如下:充血性心力衰竭(CHF;37.4%)、肺炎(19.5%)、恶性肿瘤(15.4%)、肝硬化(4.2%)和肺栓塞。6.7%患者的胸腔积液病因未明确。与中量或大量胸腔积液相比,小量胸腔积液明显更为常见(分别为 153、28 和 14 例)。几乎 80%的 CHF 患者出现小量胸腔积液,而几乎 50%的恶性肿瘤患者出现中量或大量胸腔积液。30 天死亡率从结核性胸膜炎的 0%到恶性肿瘤所致的胸腔积液(MPE)的 40%不等。
在一家大型多学科医院治疗的患者中,10.1%发现胸腔积液。CHF 是胸腔积液的主要病因。尽管 CHF 患者的 30 天死亡率相对较高,但低于类肺炎性胸腔积液和 MPE。